article · Journal of Medicine Surgery and Public Health
Artificial intelligence is gradually being integrated into oncology across Africa, offering improvements in diagnostics, treatment planning, and patient monitoring. Existing innovations already employ artificial intelligence for tissue analysis, cervical cell imaging, disease forecasting, and remote patient monitoring. Emerging tools, including mobile health applications, predictive analytics, telemedicine, and virtual tumour boards, show promise in addressing resource and geographic limitations by supporting remote consultations and multidisciplinary clinical collaborations. However, widespread integration faces significant barriers, notably algorithm bias, data privacy concerns, and inadequate regulatory frameworks. Overcoming these hurdles requires representative training datasets tailored to local contexts, stronger data protection policies, and clear deployment guidelines. Enhancing cancer care outcomes across the continent will depend on sustained investment in data infrastructure, clinical capacity building, and international partnerships to ensure safe and equitable healthcare delivery.
Cancer care across Africa often contends with severe geographic barriers and limited specialised healthcare resources. Tailored artificial intelligence tools can expand access to expert diagnostics and continuous care through remote consultations and mobile health platforms. Implementing these systems safely with proper data protections and unbiased datasets can improve treatment accessibility, reduce cancer mortality, and raise the standard of patient care.
Active commercial and deployed applications already exist in tissue diagnostics, cell imaging, and remote monitoring platforms. Primary users include oncology clinics, pathologists, and remote healthcare practitioners. Further commercial expansion depends on developing regulatory pathways, secure data infrastructure, and context-specific algorithms. While initial diagnostic and digital health products are currently active in the market, broader clinical integration remains at an applied stage needing robust policy frameworks and clinical validation.
AI-generated from the published abstract. Always read the original work before citing.
AI's potential to revolutionize oncology through enhanced diagnostics, treatment planning, and patient monitoring is well-documented globally. However, in Africa, its adoption has been slower, albeit steadily progressing. This commentary explores the integration of artificial Intelligence in cancer care across Africa, assessing its current state, challenges and future directions. It highlights significant AI innovations in cancer diagnostics, such as DataPathology, PapsAI, MinoHealth, and Hurone AI, which utilize AI for tissue analysis, cervical cell imaging, disease forecasting, and remote patient monitoring. Despite these advancements, several challenges impede AI's full integration into African healthcare systems. Key issues include data privacy and security, algorithm bias, and insufficient regulatory frameworks. The review emphasizes the necessity of robust data protection policies, representative datasets to mitigate biases, and clear guidelines for AI deployment tailored to the African context. Emerging AI technologies in Africa, such as AI-enhanced telemedicine, mobile health applications, predictive analytics, and virtual tumor boards, show promise in overcoming geographic and resource limitations. These innovations can facilitate remote consultations, continuous patient monitoring, and multidisciplinary collaborations, thereby improving cancer care accessibility and outcomes. Conclusively, recommendations for enhancing AI integration in African cancer care, including investing in data infrastructure, capacity building for healthcare professionals, and fostering international collaborations are discussed. Addressing ethical and regulatory challenges is crucial to ensure responsible and effective use of AI technologies. By leveraging AI, Africa can significantly improve cancer care delivery, reduce mortality rates, and enhance patient quality of life.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.glmedi.2024.100132
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
